CAR T-cell treatments, which are specifically designed to target cancer cells, has heralded a new era in the treatment of human cancers, particularly hematologic malignancies. But all too frequently, they exhibit a disconcerting characteristic derived from the immune system's own cells: a sh
CAR T-cell therapy, a sort of cancer treatment in which the immune system's T cells are trained to attack tumour cells, was found to be effective in mice with ovarian cancer, according to a study.
According to a study, CAR T-cell therapy, a type of cancer treatment in which the immune system's T cells are trained to attack tumour cells, is successful in mice with ovarian cancer.
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine C
Bengaluru (Karnataka) [India], October 20 (ANI/NewsVoir): Narayana Health, one of the leading healthcare chain in India, today announced that they have offered support to Immuneel Therapeutics, to build the most advanced CAR-T cell laboratory at the Narayana Health city Bengaluru. With this
Bangalore (Karnataka) /Delhi [India], October 8 (ANI/BusinessWire India): Medical emergencies can affect everyone, but when the patient is a child with an aggressive form of cancer, the urgency is multiplied. Zeus Agastya Krishna Bannerjee is an 11-year-old boy diagnosed with Acute lymphobla
Washington [US], September 2 (ANI): The treatment of various tumours has been transformed by cell-based immunotherapy, often known as CAR-T cell therapy. In order to target and combat specific forms of leukaemia and lymphoma, the treatment employs genetically engineered T cells. While it has
New York [US], December 11 (ANI): Scientists from Mount Sinai have recently found potentially serious side effects related to a new form of immunotherapy known as CAR-T cell therapy, which was recently approved for the treatment of multiple myeloma.